AI for Health by Artefact

🇬🇧 AI and the digitalization of healthcare: how to improve research, development and market access of health care products?

Nov 10, 2020 | 2:00 PM CET - 2:25 PM CET


Today, in Healthtech, we are held back by the comfort of a "familiar uncertainty" for which we have done little to challenge in the past. Many players in in silico medicine have questioned this status quo. Some have demonstrated that through computational modelling and simulation support, an initial set of evidence generated by a few hundred patients instead of 1000 could be sufficient for approval by regulators, potentially saving millions in drug and medical device development costs and reducing the time to market by years. To make this happen, the alignment of data generators, product developers and regulators is essential.